L-3 night vision systems for Aussie soldiers
L-3 Communications has received a $208 million contract from the Australian Defence Force (ADF) for night vision soldier systems, the company announced on 14 November.
The five-year contract, awarded under the ADF's LAND 53 Phase 1BR programme, follows a competitive bid process that included extensive ADF field testing.
The equipment will include targeting and detection capabilities that are designed to perform at night and under all weather conditions, including binocular night vision goggles that incorporate white phosphor image intensification technology; a compact multifunction aiming laser with integrated white light capability; and the next generation of lightweight, miniature laser rangefinders.
L-3 Warrior Systems will also open a new sustainment centre in Australia to provide in-country logistics support, as well as regional customer support, for this project.
Deliveries will take place between May 2017 and May 2021.
More from Land Warfare
-
Italy set to begin evaluation of KF41 IFV
The KF41 is entering service in Hungary and a version of it is in the running to meet the US XM30 requirement. An order from Italy could be for as many as 1,050 vehicles.
-
Egypt approved for $4.7 billion upgrade of its Abrams main battle tanks
The approval is for the upgrade of 555 of Egypt’s M1A1 Abrams tanks into M1A1SA configuration.
-
British soldiers successfully complete anti-drone EW test firing
The system beams radio waves to disrupt or damage the critical electronic components of enemy vehicles causing them to stop in their tracks or fall out of the sky. It has been described as costing only £0.10 (US$0.12) per shot.
-
Estonia signs for construction of new radar post
The new radar post will be built around Thales Ground Master radars purchased in 2023.
-
Turkey’s FNSS turns to a tank for its new armoured vehicle
The first Kaplan Armoured Personnel Carrier (APC) is due to be completed by FNSS in Turkey next year, with the second rolled out in Indonesia by Pindad, and qualification trials undertaken in both countries by 2026.